ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

BLTE Belite Bio Inc

43.20
2.10 (5.11%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Belite Bio Inc BLTE NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
2.10 5.11% 43.20 23:00:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
41.05 40.88 43.45 43.20 41.10
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:15GLOBEBelite Bio Announces Presentation at the Association for..
25/4/202418:15GLOBEBelite Bio Announces $25 Million Registered Direct Offering
22/3/202407:00GLOBEBelite Bio Announces PMDA Submission of Tinlarebant for..
11/3/202421:28GLOBEBelite Bio Announces Availability of Annual Report on Form..
11/3/202420:27GLOBEBelite Bio Reports Fourth Quarter and Full Year 2023..
06/3/202407:00GLOBEBelite Bio to Host Webcast on March 12, 2024, to Discuss..
04/3/202407:00GLOBEBelite Bio to Participate in the Leerink Partners Global..
12/2/202420:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202419:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202407:00GLOBEBelite Bio to Present at the Oppenheimer 34th Annual..
28/12/202315:16EDGAR2Form 144 - Report of proposed sale of securities
28/12/202315:15EDGAR2Form 144 - Report of proposed sale of securities
30/11/202307:00GLOBEBelite Bio to Participate in the Benchmark Company’s..
28/11/202316:16EDGAR2Form 144 - Report of proposed sale of securities
20/11/202307:00GLOBEBelite Bio to Participate in the BTIG Ophthalmology Day
16/11/202315:41EDGAR2Form 144 - Report of proposed sale of securities
16/11/202315:36EDGAR2Form 144 - Report of proposed sale of securities
13/11/202319:15GLOBEBelite Bio Reports Third Quarter 2023 Operational Highlights..
10/11/202307:35GLOBEDeutsche Bank ADR Investor Conference: Presentations Now..
07/11/202307:00GLOBEBelite Bio to Host Webcast on November 14, 2023, to Discuss..
06/11/202315:00GLOBEBelite Bio, Inc. to present at the Deutsche Bank ADR Virtual..
06/11/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202307:00GLOBEBelite Bio Presents Results from a 24-month, Phase 2 Study..
01/11/202307:35GLOBEInternational companies to host live webcasts at Deutsche..
27/10/202307:00GLOBEBelite Bio Announces Presentation at the American Academy of..
19/9/202311:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/8/202316:16EDGAR2Form 144 - Report of proposed sale of securities
31/8/202315:48EDGAR2Form 144 - Report of proposed sale of securities
09/8/202305:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202305:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

Delayed Upgrade Clock